GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response

Overview of attention for article published in Frontiers in immunology, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 35 X users

patent: 3 patents

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 96 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

METHOD FOR REPROGRAMMING CD8+ T CELLS TO ENHANCE THEIR THERAPEUTIC POTENTIAL AND…

Application WO-2023139242-A1

World Intellectual Property Organisation (WIPO)

COVID-19 THERAPEUTIC AGENT AND USE OF COMPOUND FOR PRODUCING COVID-19 THERAPEUTIC AGENT

Application WO-2022250100-A1

World Intellectual Property Organisation (WIPO)

COMPOSITION FOR USE IN THE TREATMENT OF COVID-19

Application WO-2022195558-A1

World Intellectual Property Organisation (WIPO)